1 In acute respiratory distress syndrome (ARDS) induced by endotoxins, a high production of in¯ammatory mediators by microvascular lung endothelial cells (LMVEC) can be observed. Activation of cells by endotoxins may result in elevated secretion of phospholipase A 2 (sPLA 2 ) which is thought to contribute to tissue damage. The present study was undertaken to investigate the role of sPLA 2 in chemokine production in human lung microvascular endothelial cells (LMVEC) stimulated with the endotoxins lipopolysaccharide (LPS) and lipoteichoic acid (LTA). In particular, we investigated the eects of sPLA 2 inhibitors, speci®cally, the extracellular PLA 2 inhibitors (ExPLIs), composed of N-derivatized phosphatidyl-ethanolamine linked to polymeric carriers, and LY311727, a speci®c inhibitor of non-pancreatic sPLA 2 . 2 ExPLIs markedly inhibited LPS and LTA induced production and mRNA expression of the neutrophile attracting chemokines IL-8, Gro-a and ENA-78, as well as of the adhesion molecules ICAM-1 and E-selectin. Concomitantly, ExPLIs inhibited the LPS-induced activation of NF-kB by LPS but not its activation by TNF-a or IL-1. 3 Endotoxin mediated chemokine production in LMVEC seems not to involve PLA 2 activity, since LPS stimulation was not associated with activation of intracellular or secreted PLA 2 . It therefore seems that the inhibitory eect of the ExPLIs was not due to their PLA 2 inhibiting capacity. This was supported by the ®nding that the LPS-induced chemokine production was not aected by the selective sPLA 2 inhibitor LY311727. 4 It is proposed that the ExPLIs may be considered a prototype of potent suppressors of speci®c endotoxin-induced in¯ammatory responses, with potential implications for the therapy of subsequent severe in¯ammation.
Introduction
Acute respiratory distress syndrome (ARDS) is a clinically and pathophysiologically complex syndrome of acute lung in¯ammation. Various injurious and noxious substances may initiate ARDS, but the most frequent causes with severe in¯ammation are due to bacterial toxins like lipopolysaccharide (LPS) and lipoteichoic acid (LTA) (Middelveld & Alving, 2000) . (Schaefers et al., 1996; Holm et al., 1991) . Furthermore it has been reported, that sPLA 2 regulates cytokine production and generation of reactive oxygen species .
PLA 2 hydrolyzes membrane phospholipids (PL) at the sn-2 position, releasing free fatty acids and phospholipids. The PLA 2 s include the intracellular enzymes, speci®cally the cytosolic (cPLA 2 ) and calcium-independent (iPLA 2 ) ones, and the subfamily of secreted enzymes (sPLA 2 ) (Six & Dennis, 2000) . cPLA 2 has been reported to play an important role in the development of ARDS, as it is speci®c to PL that carry arachidonic acid, the precursor of pro-in¯ammatory eicosanoids (Nagase et al., 2000) . Yet, under in¯ammatory conditions, the majority of AA is produced by sPLA 2 (Nevalainen et al., 2000) . In addition to producing lipid mediators, sPLA 2 secreted into the extracellular¯uid synergizes with other pro-in¯ammatory mediators in tissue damage occurring at in¯ammatory sites (Dan et al., 1996; Ginsburg et al., 1997 ) . It has been suggested that degradation of cell surface glycosaminoglycans (GAG) by reactive oxygen species (Dan et al., 1996) and heparinase (Kim et al., 2001) render the cell membrane accessible to lysis by exogenous sPLA 2 . Recently, the existence of distinct sPLA 2 -subtypes was de®ned in human lung under septic conditions. The sPLA 2 -IB, primarily isolated from pancreas, was detectable during lung in¯ammation as a complication of an acute pancreatitis (Tsukahara et al., 1999) . The sPLA 2 -IIA, produced by dierent cell types, e.g. smooth muscle cells and epithelial cell (Pfeilschifter et al., 1989) and isolated from in¯ammatory¯uids, was found to be highly upregulated in bronchoalveolar lavage-¯uid (Samet et al., 1996) . Manifestations of sPLA 2 -associated lung dysfunction, mainly vasodilation and vascular permeability, have been proposed to be mediated either via direct action of sPLA 2 itself (Vadas & Pruzanski, 1986) or derivatives of its action, such as eicosanoids and platelet-activating-factor (Demling, 1993) . In addition to these well characterized sPLA 2 isoenzymes, mRNA expression of sPLA 2 -V and X was recently detected in mammalian lungs, but their functions in in¯ammatory processes are still unclear (Seeds et al., 2000) .
Characteristic for endotoxin-induced cellular responses in the lung are the extravasation and accumulation of activated neutrophils (PMN) . PMN adhere to the endothelium via adhesion molecules and through endothelial-derived chemokines they migrate along a chemotactic gradient into the in¯ammed tissue. In lung microvascular endothelial cells members of the CXC-chemokine family IL-8, Gro-a and ENA-78 exhibit strong chemotactic activities to PMN and are strongly upregulated after LPS stimulation (Beck et al., 1999) . Furthermore, the EC adhesion molecules ICAM-1 and E-selectin, which are involved in mediating PMN adherence, are elevated under endotoxin stimulation (Jersmann et al., 2001) .
Cell stimulation by endotoxins has been reported to involve activation of sPLA 2 in several cell types, such as epithelial cells or astrocytes (Grossman et al., 2000; Wang & Sun, 2001) . In order to gain insight into the role of endothelial sPLA 2 in the pathophysiology of ARDS, we explored the involvement of sPLA 2 in LPS-induced production of pro-in¯ammatory chemokines by human LMVEC, and the possibility of controlling this process by inhibition of sPLA 2 activity. To this end, we employed extracellular PLA 2 inhibitors (ExPLIs), designed and synthesized in the laboratory of S. Yedgar. These are composed of lipidic inhibitors of PLA 2 , e.g. N-derivatized phosphatidyl-ethanolamine (PE), linked to polymeric carriers, such as hyaluronic acid (Dan et al., 1998; Yedgar et al., 2000) . While the lipid moiety incorporate into the cell membrane, the polymeric carrier prevents its internalization. By combining a GAGmimicking polymer anchored to the cell membrane by the PLA 2 inhibiting lipid, the ExPLIs might exhibit a dual eect in protecting cells from PLA 2 and pro-in¯ammatory mediators. Accordingly, they have been found eective in blocking the action of dierent exogenous PLA 2 s (Dan et al., 1998) . Moreover, they suppress the activation of endogenous PLA 2 induced by ROS in epithelial cells Ginsburg et al., 1997) or LPS in macrophages (Balsinde et al., 2000) , and protect cells from damage induced by oxidizing agents and hemolysins Ginsburg et al., 1997) . In previous studies ExPLIs were found to be eective in ameliorating delayed type hypersensitivity in mice (Yedgar et al., 1994) , and bleomycin-induced lung injury in hamsters . On these grounds, in the present study we have employed the ExPLIs and LY-311727, a speci®c sPLA 2 inhibitor (Schevitz et al., 1995) to explore the role of sPLA 2 in endotoxin-induced production of chemokines and adhesion molecules by LMVEC.
Methods

Materials
Essential growth medium for microvascular cells (EGM-MV) and Trypsin 0.025 Vol%/EDTA 0.01 Vol% (T/E) were from CellSystems, Remagen, Germany. Antibodies against ICAM-1 and E-selectin were purchased from DAKO, Glostrup, Denmark. LPS, LTA, TNF-a, IL-1 and hyaluronic acid were from Sigma, Deisenhofen, Germany. IL-8, Gro-a and ENA-78 Immunoassays were obtained from R&D Systems GmbH, Wiesbaden, Germany. The primers of the chemokines IL-8, Gro-a and ENA-78 were designed by Perkin Elmer applied Biosystems, Weiterstadt, Germany. Trizol-Reagent, DNAse and dNTPs were from Gibco BRL, Eggenstein Germany. SuperScript TM II Pre-ampli®cation System was purchased from Life Technologies, Karlsruhe, Germany. Gel shift assay system was from Promega Corporation, U.S.A. BSA and Light Cycler-FastStart DNA Master SYBR GreenI ready-to-usè Hot start' reaction mix were from Roche, Mannheim, Germany. C-oleic acid-labelled Escherichia coli membranes were synthesized as described previously (Scholz et al., 1999) . LY311727 was a generous gift from Eli Lilly Company Green®eld, Indiana, U.S.A. Anti TLR-4 m-ab was from Biocarta, San Diego, California, U.S.A. Extracellular PLA 2 inhibitors (ExPLIs) were synthesized in the laboratory of S. Yedgar. The ExPLIs used in the present study are composed of N-derivatized dipalmitoyl-phosphatidylethanolamine (PE) linked to one of the following compounds: truncated hyaluronic acid (HyPE); chondroitin sulphate A (CSAPE); carboxymethyl-methylcellulose (CMPE); or aspirin (AsPE). All these compounds were free of endotoxins demonstrated in Limulus amebocyte lysate (Bio Whittaker Comp., Walkersville, U.S.A.).
Cell culture
Human lung microvascular endothelial cells (LMVEC) were purchased from CellSystems, Remagen, Germany at passage 4. The cells were seeded in a density of 5000 cells cm 72 in T25 asks and maintained according to the manufacturer's speci®cation in EGM-MV. After con¯uency they were subcultured as described previously (Beck et al., 1999) .
Characterization of the LMVEC was performed on the basis of a positive staining for uptake of acetylated LDL, Factor VIII related antigen and PECAM (CD31) expression as well as negative staining for alpha smooth muscle actin.
In each experiment the viability of LPS-and LTAstimulated or HyPE treated LMVEC was tested by Trypan blue exclusion.
Chemokine production LMVEC were seeded in 24-well plates and grown to con¯uence. The cells were stimulated for 24 h with medium as control or with LPS (Escherichia coli (1 mg ml 71 )), LTA (Staphylococcus aureus (10 mg ml 71 )), IL-1 (1 ng ml
71
) or TNF-a (500 U ml 71 ) in the presence or absence of HyPE (0.1 ± 20 mM). Alternatively cells were pretreated with LPS or LTA several hours before HYPE was added. Supernatants were collected and the production of ENA-78, Gro-a and IL-8 was measured.
All ELISAs were performed according to the manufacturer's instructions.
RNA isolation and polymerase chain reaction
RT ± PCR: Con¯uent LMVEC were stimulated with medium as control or with LPS (1 mg ml
71
) or LTA (10 mg ml 71 ) in the presence or absence of HyPE (10 mM). Total RNA was isolated using Trizol-Reagent according to the manufacturer's instructions. Each RNA preparation was subjected to DNAse digestion to remove possible contaminations of genomic DNA. Total RNA, (1 mg) was reverse transcribed using SuperScript TM II Pre-ampli®cation System according to the manufacturer's instructions. The oligonucleotides (primers) used for PCR are listed in Table 1 . Ampli®cation of 0.5 ml of cDNA was performed in a total volume of 25 ml containing 19.6 pmol of each chemokine primer: (mM) dNTPs 5, 2.5 U Taq Polymerase, Tris HCl 10, KCl 7.5, MgCl 2 1.5. PCR reactions were initiated at 948C for 3 min, followed by 30 cycles of ampli®cation, each consisting of 948C for 1 min, 588C for 1 min, 728C for 2 min. At the end of the ampli®cation cycles the products were incubated for 10 min at 728C. Control samples were constructed either by omitting cDNA synthesis or without addition of cDNA. PCR products were separated on a 1% agarose gel.
Real-time PCR: 500 ng of total RNA of each sample was in addition reverse transcribed into cDNA for Real-time PCR analysis using 1st Strand cDNA Synthesis Kit according to the manufacturer's instructions (Roche). cDNA was diluted in 20 ml DEPC-treated water. DNA standards were generated by PCR ampli®cation of gene products, puri®cation and quanti®cation by spectrophotometry. Real time PCR of cDNA specimens and DNA standards were performed in a total volume of 25 ml in the presence of 2 ml Light cycler ± FastStart DNA Master SYBR GreenI reaction mix, 0.5 mM of gen-speci®c primers and 4 mM MgCl 2 . Standard curves were generated for all chemokines. PCR eciency was assessed from the slopes of the standard curves and was found to be between 90 and 100%. Concentration of chemokine cDNA was calculated by linear regression analysis of all standard curves and was corrected for an equal expression of GAPDH. At least ®ve experiments with similar results were performed.
Analysis by fluorescence-activated cell sorter (FACS)
Con¯uent LMVEC were stimulated with medium as control or with LPS (1 mg ml 71 ) or LTA (10 mg ml 71 ) in the presence or absence of HyPE (10 mM). Thereafter cells were harvested by T/E, extensively washed, and monoclonal antibodies directed against the endothelial adhesion molecules ICAM-1 and E-selectin in dilutions of 1 : 20 were added for 30 min at 48C. In addition unstimulated or stimulated cells were harvested as described and preincubated for 20 min with HyPE (10 mM) and monoclonal antibodies against TLR4. Cells were washed and incubated with an anti-mouse F(ab')2, FITC conjugated secondary antibody. After washing cells were analysed by FACS-scan.
Electrophorese mobility shift assay (EMSA)
Con¯uent LMVEC were pre-incubated over night in basal medium containing 0.01% BSA. Hereafter they were stimulated or not for dierent time periods with LPS, IL-1 or TNF-a in the presence or absence of HyPE. Nuclear extracts were prepared as described previously (Hilschermann et al., 1996) . Oligonucleotides containing a NF-kB consensus sequence (5'-AGT TGA GGG GAC TTT CCC AGG C-3') were labelled to a speci®c activity 456107 c.p.m. mg 71 DNA. NF-kB-binding was performed in (mM) HEPES 10, (pH=7.5), EDTA 0.5, KCl 70, DTT 2, 2% glycerol, 0.025% NP-40, 4% Ficoll, 0.1 M PMSF, 1 mg ml 71 BSA and 0.1 mg ml 71 poly di/dc in a total volume of 20 ml. Nuclear extracts (10 mg) were incubated for 30 min at room temperature in the presence of 1 ng labelled oligonucleotide. DNA-protein complexes were resolved on 5% non-denaturating polyacrylamide gels electrophoresed in low ionic strength buer and visualized by autoradiography. Speci®ty of shifted bands were demonstrated by adding a cold NF-kB consensus sequence or by supershift using anti-p65 antibodies. 
Determination of the secretion of sPLA 2 -activity Secretion of sPLA 2 -activity to the culture medium by LMVEC was determined using Escherichia coli membranes labelled with 1-14 C-oleate as a substrate, as described previously (Scholz et al., 1999) . Con¯uent LMVEC were incubated in control medium or stimulated with LPS (1 ± 5 mg ml 71 ) in the absence or presence of HyPE (10 mM) for 24 h, when the culture medium was collected. Since sPLA 2 may bind to cell surface proteoglycans, this was done following the addition of heparin to the culture prior to collecting the culture medium, in order to detach sPLA 2 from the cell surface (Suga et al., 1993) . sPLA 2 activity in the collected medium was measured as follows: The assay mixtures (750 ml) contained 100 mM Tris/Cl pH=8.0, 100 mM CaCl 2 , 0.1% BSA, with (1-14 C-oleic acid-labelled Escherichia coli, 5000 c.p.m.) and the enzyme-containing culture. The reaction mixture was incubated for 30 min at 378C. The reaction was stopped by the addition of 50 ml 1 mM EGTA/1 N HCl and 800 ml ethyl acetate. The lipid-containing phase was collected and dried in a vacuum concentrator. The dry lipids were dissolved in 50 ml ethyl acetate and separated by thin layer chromatography on silica gel G 60 plates using the organic phase of ethyl acetate : isooctane : acetic acid : water (110 : 50 : 20 : 100 by volume) as a solvent system. Detection and quanti®cation of the released fatty acid was performed with a Linear Analyzer (Bertold, Wildbad, Germany). In parallel experiments the extraction eciency was found to be greater than 95%.
Determination of
3 H-arachidonic (AA) -and 3 H-oleic acid (OA)-release LMVEC were grown in 12-well plates until con¯uency. Thereafter they were washed twice with serum-free EBM and incubated with 0.2 mCi/ml of [ ) with or without HYPE (10 mM) or palmitoyllysophosphatidylcholine-(LPC) (50 mM) for 24 h. Supernatants were collected and counted. The values of the released radioactivity were then expressed as per cent of the total radioactivity incorporated into the cells before the addition of LPS or LPS with HyPE or LPC.
Statistical analysis
Statistical analysis was performed using Stata Statistical software (Mann ± Whitney test). A P-value of P50.05 was considered as signi®cant.
Results
Effects of HYPE on the production of chemokines and expression of adhesion molecules in LPS-stimulated LMVEC It has previously been shown that under basal conditions LMVEC have a low expression of IL-8, ENA-78 and Gro-a, which is strongly upregulated under stimulatory conditions (Beck et al., 1999) . Since it has been suggested that the action of LPS involves activation of sPLA 2 , the present study was conducted to examine sPLA 2 involvement in LPS-induced chemokine production in LMVEC. To this end we made use of an ExPLI, i.e. HyPE, that eectively inhibits sPLA 2 in vitro and in vivo (Dan et al., 1998) . While HyPE did not in¯uence the basal chemokine production (not shown), it dose-dependently inhibited LPS-mediated production of all chemokines tested ( Figure 1A) . Accordingly, HyPE suppressed chemokine mRNA expression ( Figure 1B) .
Like LPS, LTA is currently considered to be an inducer of in¯ammatory response in endothelial cells (Kawamura et al., 1995) , although its in¯uence on sPLA 2 activity has not yet been de®ned. We therefore investigated whether HyPE also inhibits LTA-induced chemokine production in LMVEC. As shown in Figure 2 , LTA strongly upregulated the production of IL-8, although to a lesser extent than LPS. Again it was found that HyPE suppressed this production in a dose-dependent manner. The same results were obtained for ENA-78 and Gro-a (data not shown). Whereas a signi®cant upregulation in LPS-mediated chemokine production was observed already after 6 h of stimulation ( Figure 3A) , upregulation hereof by LTA occured much later ( Figure 3B ). When HyPE was added to the cell culture in the presence of either stimulus, the upregulation was not observed even after prolonged stimulation.
Since extravasation and migration of neutrophils to in¯ammed lung tissue is initiated by adherence to the EC surface via adhesion molecules, we examined if HyPE was also able to inhibit the expression of ICAM-1 and E-selectin in LPS-stimulated LMVEC. Both ICAM-1 and E-selectin were expressed at a low level under unstimulated conditions and were highly upregulated by stimulation with LPS. Similar to its eect on chemokines, HyPE inhibited the upregulation of mRNA-expression and protein synthesis of these molecules ( Figure 4A,B) .
Activation of NF-kB by LPS is inhibited by HyPE
It is generally accepted that LPS-induced production of chemokines and adhesion molecules is dependent on activation of the transcription factor NF-kB (Oitzinger et al., 2001) . Therefore, the in¯uence of HYPE on LPS-induced activation of NF-kB in LMVEC was investigated by performing EMSA. Maximal activation of NF-kB was found between 6 and 10 h after stimulation with LPS. In concordance to its eect on the expression of chemokines and adhesion molecules, HyPE suppressed LPS-induced activation of NF-kB in LMVEC ( Figure 5 ). TNF-a induced NF-kB-activation could not be prevented by HyPE (data not shown).
Role of PLA 2 in LPS-induced chemokine production
In endotoxin-infected lungs, sPLA 2 is found to be highly upregulated, and is believed to play an important role in the pathophysiology. In accordance with this, LPS has been found to activate sPLA 2 in dierent cells (Doer¯er et al., 1994; Fouda et al., 1995) , however data on direct activation of sPLA 2 in LPS stimulated endothelial cells are lacking (Flynn & Ho, 1995) . Therefore we examined the LPS eect on secretion of sPLA 2 by A B Figure 1 Eect of HyPE on LPS-induced chemokine production. (A) LMVEC were either incubated in control medium (black bar) or stimulated for 24 h with LPS (1 mg ml 71 ) in the presence (open bar) or absence of HyPE at the indicated concentrations (grey bars). Thereafter, the supernatants were collected and assessed for chemokine production by ELISA. Each value represents the mean production of triplicate cultures+s.d.. *P50.05 compared to cells that were stimulated only with LPS. (B) LMVEC were treated as in (A) and harvested using Trizol-Reagent. Total RNA was isolated and RT ± PCR was performed as described in Methods. Five experiments with similar results were performed. The results of one represenative experiment is shown. LMVEC by determining its activity in the extracellular medium subsequent to their stimulation with LPS, IL-1, TNF-a or combinations thereof. No elevation of sPLA 2 -activity in the cell culture medium was detected following treatment with LPS and the other stimulators (data not shown), suggesting that sPLA 2 is not involved in the LPS-induced endothelial chemokine production. In accordance with this it was found that LY311237 ± a known inhibitor of sPLA 2 IIA, V and X (Schadow et al., 2001) , but not of IB or cPLA 2 (Schevitz et al., 1995) ± did not aect LPS-induced chemokine production by LMVEC (Figure 6 ).
Subsequent to the ®nding that activation of LMVEC by LPS does not involve secretion of sPLA 2 , we examined whether PLA 2 activity is involved in this process at all, by utilizing the speci®city of cPLA 2 to arachidonic acid-containing phospholipids. To this end, phospholipids of LMVEC were metabolically labelled with 3 H-AA or OA, and the release of free fatty acids was monitored subsequent to stimulation with LPS. As shown in Figure 7 , no increase in the release of either of these fatty acids was observed after LPS stimulation, suggesting that PLA 2 activation is not involved in LPS-induced chemokine production by LMVEC.
Mechanism of HyPE action
As described above, HyPE is an amphipatic complex, which is anchored to the cell membrane by its lipophilic moiety (PE), whereas hyaluronic acid resides at the cell surface. It could thus be argued that the inhibitory eect of HyPE was due to steric hindrance of the polymeric carrier interfering with the interaction of LPS with its receptor at the cell surface. To examine this possibility, we determined the eect of HyPE when it is added to the cell culture after LPS. Figure 8 shows that in this model the inhibition of IL-8 production by HyPE was inversely proportional to the time at which HyPE was added after LPS. This could suggest that HyPE interferes with the signalling downstream after LPS by interaction with its receptor. However, Figure 8 also depicts an experiment in which LPS-containing medium was replaced with LPS-free medium at dierent times post-stimulation. The results of this experiment show that this treatment was comparable with the addition of HyPE; the reduction in IL-8 production was inversely proportional to the time at which the LPS was washed away. Taken together, these results still leave open the possibility that HyPE, via its extracellular polymeric moiety, interfere with the LPS interaction with its receptor.
To further examine this possibility, we performed two kinds of experiments: Firstly, it was tested whether HyPE prevents the binding of antibodies against the transmembrane LPS-receptor TLR4. Figure 9 shows that in the presence of HyPE, LPS ± TLR4 interaction was partly inhibited, while under the same conditions, IL-8 production was completely blocked. This seems to support the notion that at least part of the HyPE inhibitory eect is due to interference with LPS interaction with its receptor. However, in another experiment we employed dierent ExPLIs, in which the PE moiety was coupled either to polymers that dier in their chemical nature ± speci®cally chondroitin sulphate A (CSAPE) and carboxymethylcellulose (CMPE) ± or aspirin (ASPE), as a non polymer-containing inhibitor. It was obtained that all of these inhibitors suppressed LPS-induced chemokine production, while the polymers or aspirin alone were ineective (data not shown). In addition, HyPE did not inhibit chemokine production by LMVEC induced by TNF-a or IL-1, which are also strong stimuli of endothelial chemokine production during in¯ammatory processes like ARDS (data not shown). It thus seems that steric hindrance by the ExPLIs can explain in part the ExPLIs inhibitory eect on LPS-induced chemokine production.
Discussion sPLA 2 has been assumed to play an important role in the development of ARDS, as elevated PLA 2 activity in the serum of patients with septic shock was found to be associated with an increased risk for the development of Function of LPS mediated chemokine production by HyPE. LMVEC were either stimulated with LPS (1 mg ml 71 well) (boxes) or at the indicated time after LPS stimulation HyPE was added to the wells (triangles) or cell culture supernatants were collected (LPS was washed out) and normal medium was added (points). The culture medium in all wells was collected after 72 h and assessed for IL-8 production by ELISA. Each value represents the mean production of triplicate cultures+s.d. *P50.05 LMVEC pretreated with LPS before HyPE addition compared to cells that were stimulated only with LPS. #P50.05 LMVEC pretreated with LPS before washing compared to cells that were stimulated only with LPS.
ARDS (Vadas & Pruzanski, 1993) , and increased sPLA 2 levels in bronchoalveolar-¯uid correlated with the severity of ARDS (Oenstadt et al., 1981) . This was supported by the ®nding that sPLA 2 infusions into the pulmonary circuit of dogs and rats (Littner & Lott, 1990) induce changes resembling those observed in ARDS, and intratracheal administration of sPLA 2 caused similar histological injury and clinical symptoms (Edelson et al., 1991) .
In accordance with this, studies with dierent cultured cells have suggested that the cellular stimulation by LPS per se involves the activation of sPLA 2 . It has thus been assumed that sPLA 2 acts as an important mediator of pathophysiology of endotoxin-induced ARDS (Partrick et al., 2001) . Accordingly, inhibition of sPLA 2 activity has been considered for the treatment of ARDS. A number of inhibitors have been proposed and tested in vitro for this purpose, but were found unsatisfactory or toxic when tested in vivo (Yokota et al., 1999; Song et al., 1999) .
However, the present study suggest that in LMVEC stimulation by endotoxins does not involve sPLA 2 , since no activation or secretion of PLA 2 were observed upon treatment of these cells with LPS or by highly in¯ammatory cytokines combinations. This was supported by the ®ndings that the speci®c sPLA 2 inhibitor LY311727 had no eect on the production of chemokines or adhesion molecules in LMVEC. It should be stressed that PLA 2 activation in endothelial cells can be observed when appropriate stimuli are used. However, data on endothelial sPLA 2 -activity are inconclusive (Wong et al., 2000) and the formation of eicosanoids in endothelial cells may be mainly attributed to the activity of cPLA 2 (Doer¯er et al., 1994; Fouda et al., 1995) . This does not rule out the possibility that exogenous sPLA 2 , secreted by other cells or tissues in body¯uid of ARDS patients, may aect LMVEC by inducing the production of in¯ammatory mediators by these cells.
The present study raises particular interest in the ExPLIs, which are composed of a PLA 2 inhibiting phospholipid that incorporates into the cell membrane (Dan et al., 1998) , linked to a GAG-mimicking polymer, which prevents its internalization. This structure makes them potent inhibitors of endogenous PLA2 activation, by LPS (Balsinde et al., 2000) and other in¯ammatory agents Ginsburg et al., 1997) , and protectors of cells from exogenous in¯ammatory mediators, such as ROS, hemolysins and sPLA 2 (Ginsburg et al., 1997; Dan et al., 1998; Yard et al., 2002) . In the present study it was found that the ExPLIs dramatically suppressed LTA and LPSinduced production of CXC chemokines and expression of adhesion molecules. Since, as shown in this study, the action of endotoxins on LMVEC is independent of PLA 2 activity, it follows that the inhibition of the LPS responses by the ExPLIs is not due to their PLA 2 -inhibiting capacity, but via a dierent mechanism. Since the TNF-a-induced NF-kB activation was not in¯uenced by HyPE, it seems that the ExPLIs interfere with the LPS signalling pathway. Figure 8 shows that LPS-induced chemokine production in LMVEC is proportional to stimulation duration; the stimulation can be stopped by washing LPS away or by addition of HyPE, thus suggesting that HyPE competes with LPS. This was supported by the ®nding that the binding of TLR to its antibody is reduced by HyPE (although not completely). This of course does not necessarily rule out binding of LPS with its receptor, but if we interpolate from the TLR antibody to LPS, it may be suggested that the ExPLIs interfere with the interaction of endotoxins with the receptor at the cell surface. However, the LPS action was inhibited as well by dierent ExPLIs, in which the inhibiting lipid is linked to polymeric carriers that dier in size and chemical nature or to aspirin (Figure 10 ). This suggests that simple steric hindrance does not fully explain the mechanism by which the ExPLIs suppress endotoxin-induced chemokine production by LMVEC.
LPS is an amphipathic, negatively-charged molecule, and it has long been proposed that its action involves ionic interaction with the membrane and intercalation of its lipid moiety (lipid A) into the lipid bilayer, in addition to receptor binding (Jacobs et al., 1990) . The ExPLIs used in the present study (including ASPE) are negatively charged, and anchored to the cell membrane via their lipid moiety (PE). It is thus not unlikely that the ExPLIs interfere as well with these LPS interactions with the membrane and/or with the incorporation of Lipid A into the lipid bilayer, but the exact mechanism of the ExPLIs' inhibitory eect has yet to be explored.
The present study demonstrates that the inhibitory eect of the ExPLIs is expressed at mRNA level of the chemokines and adhesion molecules. Moreover, this inhibitor suppresses the activation of NF-kB, a transcription factor that mediates LPS-induced gene expression.
In summary, the ExPLIs are potent protectors of cells from damage by exogenous sPLA 2 s and other cell in¯ammatory agents Ginzburg et al., 1997; Dan et al., 1998; Schnitzer et al., 2000; Balsinde et al., 2000; Yard et al., 2001) . Although the exact mechanism of the ExPLIs action in LMVEC remains to be investigated, all-in-all, these ®ndings present the ExPLIs as potent inhibitors of endotoxin-induced cellular responses, and may introduce a novel approach in the research and therapy of ARDS. Eect of HyPE on binding of anti TLR4 antibodies. LMVEC were harvested as described and preincubated (fat line) or not (thin line) for 20 min with HyPE (10 mM). Thereafter monoclonal antibodies against TLR4 were added to the cell suspension and FACS-analysis was performed as described in Methods. Grey line=negative control.
